Thermo
Fisher ScientificFisher Scientific is an American multinational biotechnology
product development company, created in 2006 by the merger of Thermo
Electron and Fisher Scientific. In April 2013, after a competitive
bidding with Hoffmann-La Roche,[2] Thermo Fisher acquired Life
Technologies Corp for $13.6 billion in a deal that would rank the firm
as one of the leading companies in the genetic testing and precision
laboratory equipment markets.[3][4][5]

Contents

1 Predecessors and merger

1.1 Acquisition history
1.2 Acquisitions and brands currently owned by Thermo-Fisher

2 References
3 External links

Predecessors and merger[edit]
Thermo ElectronThermo Electron was co-founded in 1956 by
George N. HatsopoulosGeorge N. Hatsopoulos and
Peter M Nomikos. Hatsopoulos is a MIT PhD in mechanical engineering
and Nomikos a
Harvard Business SchoolHarvard Business School graduate.[6] It focused on
providing analytical and laboratory products and services, and had
revenues of over $2 billion in 2004.[7]
Fisher ScientificFisher Scientific was founded in 1902 by Chester G. Fisher from
Pittsburgh.[8][9] It focused on providing laboratory equipment,
chemicals, supplies and services used in healthcare, scientific
research, safety, and education.[10]
On May 14, 2006,
Thermo ElectronThermo Electron and
Fisher ScientificFisher Scientific announced that
they would merge in a tax-free, stock-for-stock exchange; the merged
company was named Thermo Fisher Scientific.[11] On November 9, 2006,
the companies announced that the merger had been completed.[11]
However, the
Federal Trade CommissionFederal Trade Commission ruled that this acquisition was
anticompetitive with regard to centrifugal evaporators, requiring
Fisher to divest Genevac.[12] In April 2007,
Genevac was sold to
Riverlake Partners LLC[13] and the merger closed with FTC
approval.[14]
Currently, the company's products are sold under the brand names of
Thermo Scientific, Fisher Scientific, and several other recognized
brand names (e.g. Chromacol, Nalgene, Cellomics, Pierce Protein
Research and Fermentas). According to company figures, 46% of its
sales are in life sciences, 20% in healthcare, and 34% in
industrial/environmental and safety.[10]
Thermo Fisher has offices and operations in many countries, notably
the U.S. and in Europe.
In May 2011, Thermo
Fisher ScientificFisher Scientific Inc. bought
Phadia to expand in
testing for allergies and autoimmune diseases for €2.47 billion
($3.5 billion) in cash purchase.[15]
In 2013 Thermo Fisher agreed to buy Life Technologies for $13.6
billion. The sale was completed on 4 February 2014, and the Life
Technologies brand became part of the Life Sciences Solutions Group of
Thermo Fisher Scientific.
In February 2015, the company announced it would acquire Advanced
Scientifics for $300 million in a cash-deal. ASI designs, manufactures
and delivers technologies used in bioprocessing solutions.[16] In June
2015, the company announced its intention to acquire Alfa Aesar, a
global manufacturer of research chemicals for $405 million[17] from
Johnson Matthey, and the acquisition was completed at the end of
September[18]
In January 2016, the company announced it would acquire
AffymetrixAffymetrix for
$1.3 billion.[19] On May 27, 2016, the company announced it would
acquire
FEI CompanyFEI Company for $4.2 billion, a manufacturer of electron
microscopes.[20][21] This acquisition is anticipated to close in early
2017 and will contribute to the growth of Thermo's Analytical
Instruments business group.[22] In November the company announced it
would acquire MTI-GlobalStem, a previously privately held company that
develops reagents for cell transfection, neurobiology and stem cell
research.[23]
In February 2017, the company acquired Finesse Solutions, Inc.,
developer of scalable control automation systems and software for
bioproduction after receiving early termination of the waiting period
under the Hart-Scott-Rodino Antitrust Improvements Act.[24] The
transaction was completed a day later.[25] In March, the company
announced it would acquire Core Informatics, provider of cloud-based
platforms supporting scientific data management.[26] In May, the
company announced it would acquire CDMO, Patheon, for $7.2
billion.[27]
Acquisition history[edit]
The following is an illustration of the company's major mergers and
acquisitions and historical predecessors (this is not a comprehensive
list):

Illustration of the company's mergers, acquisitions, spin-offs and
historical predecessors

This section needs additional citations for verification. Please help
improve this article by adding citations to reliable sources.
Unsourced material may be challenged and removed. (July 2017) (Learn
how and when to remove this template message)